Publishers scrap over open access

Share this article:
An effort by scientific and medical publishers to push back against the “open access” movement ignited a spat in the pages of Nature magazine.

Nature reported that at the behest of the Association of American Publishers, Elsevier, Wiley and American Chemical Society staff met with a Washington PR man to talk about defending their business against proponents of public access to scientific research.

The AAP called the article “misleading” for implying unsavory PR tactics on the part of publishers. AAP chair Brian D. Crawford said: “All this debate boils down to is some people wanting something for nothing.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.